MedPath

The changes of renin, angiotensin and aldosterone with long term administration of olmesartan:COMPATIBLE extension study

Not Applicable
Conditions
Hypertension
Registration Number
JPRN-UMIN000015323
Lead Sponsor
Kanagawa Association of Medical and Dental Practitioners
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

The patient who do not take Olmesartan.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Aldosterone concentration
Secondary Outcome Measures
NameTimeMethod
Renin Angiotensin I Angiotensin II Urinary albumin-to-creatinine ratio
© Copyright 2025. All Rights Reserved by MedPath